# National Marrow Donor Program

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/national-marrow-donor-program/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 72.5 |
| Citations | 191,392 |
| City | Minneapolis |
| Country | US |
| Description | National Marrow Donor Program is a research organisation in Minneapolis, US. OpenAlex records 2,217 works and 191,392 citations for it. 506 researchers list it as their most recent affiliation. |
| Homepage | https://bethematch.org/ |
| OpenAlex ID | https://openalex.org/I1318116459 |
| Region | Minnesota |
| Researchers | 506 |
| ROR ID | https://ror.org/016cke005 |
| Type | nonprofit |
| Works | 2,217 |

## University papers

- [Current Use of and Trends in Hematopoietic Cell Transplantation in the United States](https://scholariq.org/papers/current-use-of-and-trends-in-hematopoietic-cell-transplantation-in-the-united/)
- [Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine](https://scholariq.org/papers/clinical-response-and-i-mir-29b-i-predictive-significance-in-older-aml-patients/)
- [Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research](https://scholariq.org/papers/increasing-incidence-of-chronic-graft-versus-host-disease-in-allogeneic/)
- [Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial](https://scholariq.org/papers/disabling-immune-tolerance-by-programmed-death-1-blockade-with-pidilizumab-after/)
- [Outcome of Transplantation for Myelofibrosis](https://scholariq.org/papers/outcome-of-transplantation-for-myelofibrosis/)
- [Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial](https://scholariq.org/papers/autologous-transplantation-consolidation-and-maintenance-therapy-in-multiple/)

## University top topics

Showing 8 of 25.

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.